Galapagos | GLPG - Market Capitalization

Stock Price
28.48
Daily Change
0.86 3.11%
Monthly
0.07%
Yearly
19.26%
Q1 Forecast
27.05

Galapagos reported EUR1.86B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 38.95B 12.88B Mar/2026
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
GRIFOLS EUR 4.43B 3.06B Mar/2026
Hikma Pharmaceutical USD 2.92B 1.72B Mar/2026
Incyte USD 19.39B 2.83B Dec/2025
Merck EUR 47.3B 6B Mar/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025